English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Biomarin Pharmaceuticals
Carol Ostrow
| Dec 28, 2017
BioMarin presents revised clinical data for hemophilia A treatment
Ruth de Jauregui
| Jun 8, 2017
BioMarin's Brineura gets European approval for treating CLN2 brain disease in children
Chandra Lye
| May 4, 2017
Drug offers hope for children with rare brain disease
Caitlin Nordahl
| Apr 24, 2017
BioMarin, Par reach settlement on Kuvan
Jeff Gantt
| Dec 18, 2016
BioMarin Pharmaceutical initiates phase 3 vosoritide trial
Amanda Rupp
| May 11, 2016
BioMarin releases EMA grants for Batten disease treatment
Trending
+
Pharmaceuticals
Patient Daily
| Jun 18, 2025
ENT specialist on acid reflux: ‘You actually have a structural issue that may predispose you to sinusitis’
+
Pharmaceuticals
Patient Daily
| Jun 16, 2025
American Consumer Institute questions hospital use of 340B Drug Pricing Program
+
Pharmaceuticals
Patient Daily
| Jun 13, 2025
Data scientist: ‘340B sales growth was 115.5% higher than the growth of non-340B sales in 2023’
+
Pharmaceuticals
Patient Daily
| Jun 19, 2025
Patients Come First spokesperson on 340B reform: ‘Americans deserve a system that prioritizes patients first, not pharmacy middlemen’
